All News about Pardes Biosciences, Inc. - Common Stock
![](https://cdn.benzinga.com/files/images/story/2022/08/26/image_7.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_12727.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/06/24/image12_0.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/06/27/image19.jpg?width=1200&height=800&fit=crop)
![](https://www.investors.com/wp-content/uploads/2020/11/Stock-Pfizer-04-shutt.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_3058.jpeg)
![](https://cdn.benzinga.com/files/images/story/2012/aapharma_3370.png?width=1200&height=800&fit=crop)
Pardes Biosciences Clears IND Application For Oral Antiviral Candidate For COVID-19
February 03, 2022
Via Benzinga
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_11117.jpeg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/images/story/2022/movers_image_9986.jpeg?width=1200&height=800&fit=crop)
Via Benzinga
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/analyst_ratings_image_4709.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_3443.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/movers_image_2810.jpeg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_394.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/aapharma_3492.png)
![](https://www.investors.com/wp-content/uploads/2022/02/TECH1-paxlovid-021122-AP.jpg)
![](https://cdn.benzinga.com/files/images/story/2012/test-gcd00d1810_1280.jpg?width=1200&height=800&fit=crop)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_383.png)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_113.jpg)
![](https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/mid-day_movers_image_89.jpg)
![](https://cdn2.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/analyst_ratings_image_1901.jpeg?width=720)
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.